THERESA SMITH: Open Payments
NPI 1740331842 · LEWISTON, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,216 in 77 payments from 17 companies in 2025. Trend: 2023 $391 · 2024 $1,167 · 2025 $1,216
Food & beverage: $1,216
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 20 | $236 |
| ABBVIE INC. | 10 | $186 |
| GlaxoSmithKline, LLC. | 18 | $168 |
| AstraZeneca Pharmaceuticals LP | 5 | $160 |
| Novo Nordisk Inc | 8 | $135 |
| Lundbeck LLC | 2 | $51 |
| Abbott Laboratories | 3 | $50 |
| Otsuka America Pharmaceutical, Inc. | 2 | $46 |
| Teva Pharmaceuticals USA, Inc. | 1 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $26 |
Products named: NURTEC ODT, TRELEGY ELLIPTA, AIRSUPRA, REXULTI, QULIPTA, ELIQUIS, UBRELVY, FREESTYLE LIBRE 3.
Industry payments across ID — which companies pay providers there.
